A “new/old method” for TSH stimulation: could a third way to prepare DTC patients for 131I remnant ablation possibly exist?
L Giovanella, A Piccardo - European Journal of Nuclear Medicine and …, 2016 - Springer
A growing body of evidence supported the possibility to prepare patients affected by
differentiated thyroid cancer (DTC) at low and/or intermediate risk with recombinant human …
differentiated thyroid cancer (DTC) at low and/or intermediate risk with recombinant human …
Recombinant human thyrotropin versus thyroid hormone withdrawal in radioiodine remnant ablation for differentiated thyroid cancer: a meta-analysis.
H Fu, C Ma, L Tang, F Wu, B Liu… - The Quarterly Journal of …, 2014 - europepmc.org
Aim We aim to assess the effects of recombinant human thyrotropin (rhTSH) versus thyroid
hormone withdrawal (THW), and rhTSH-aided low doses (1.11 GBq and 1.85 GBq) versus …
hormone withdrawal (THW), and rhTSH-aided low doses (1.11 GBq and 1.85 GBq) versus …
Thyroid remnant dose: 124I-PET/CT dosimetric comparison of rhTSH versus thyroid hormone withholding before radioiodine remnant ablation in differentiated thyroid …
LS Freudenberg, C Frömke, T Petrich… - Experimental and …, 2010 - thieme-connect.com
Aim: Recombinant human thyroid-stimulating hormone (rhTSH) recently was approved as
an alternative to thyroid hormone withholding (THW) to elevate TSH for thyroid remnant …
an alternative to thyroid hormone withholding (THW) to elevate TSH for thyroid remnant …
Recombinant TSH Stimulated Remnant Ablation Therapy in Thyroid Cancer: The Success Rate Depends on the Definition of Ablation Success—An Observational …
ANA van der Horst-Schrivers, WJ Sluiter… - Plos one, 2015 - journals.plos.org
Introduction Patients with differentiated thyroid cancer (DTC) are treated with (near)-total
thyroidectomy followed by remnant ablation. Optimal radioiodine-131 (131I) uptake is …
thyroidectomy followed by remnant ablation. Optimal radioiodine-131 (131I) uptake is …
Could short thyroid hormone withdrawal be an effective strategy for radioiodine remnant ablation in differentiated thyroid cancer patients?
A Piccardo, M Puntoni, G Ferrarazzo, L Foppiani… - European journal of …, 2018 - Springer
Purpose Current guidelines recommend thyroid hormone withdrawal (THW) of 3–4 weeks
before radioiodine remnant ablation (RRA) of differentiated thyroid carcinoma (DTC). We …
before radioiodine remnant ablation (RRA) of differentiated thyroid carcinoma (DTC). We …
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy in a real-life scenario
A Campennì, L Giovanella, SA Pignata… - Nuclear Medicine …, 2015 - journals.lww.com
Objective Differentiated thyroid cancer is rare, but the incidence has been increasing in the
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …
last few decades. Early treatment is based on surgery and thyroid remnant ablation (TRA) by …
rhTSH-aided low-activity versus high-activity regimens of radioiodine in residual ablation for differentiated thyroid cancer: a meta-analysis
C Ma, L Tang, H Fu, J Li, H Wang - Nuclear Medicine …, 2013 - journals.lww.com
The effects of low-activity versus high-activity radioiodine regimens in thyroid remnant
ablation for patients with differentiated thyroid carcinoma (DTC) under recombinant human …
ablation for patients with differentiated thyroid carcinoma (DTC) under recombinant human …
Recombinant human TSH–assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone …
RM Tuttle, M Brokhin, G Omry… - Journal of Nuclear …, 2008 - Soc Nuclear Med
Recent studies have confirmed that radioactive iodine therapy after recombinant human
TSH (rhTSH) stimulation effectively ablates the normal thyroid remnant. However, no …
TSH (rhTSH) stimulation effectively ablates the normal thyroid remnant. However, no …
Thyroid remnant ablation success and disease outcome in stage III or IV differentiated thyroid carcinoma: recombinant human thyrotropin versus thyroid hormone …
VC JA, MB LM, G Moreno, RJ Marlowe… - The Quarterly Journal …, 2015 - europepmc.org
Background Most publications to date compare outcomes after post-surgical thyroid remnant
ablation stimulated by recombinant human thyrotropin (rhTSH) versus thyroid hormone …
ablation stimulated by recombinant human thyrotropin (rhTSH) versus thyroid hormone …
Clinical outcome of low-risk differentiated thyroid cancer patients after radioiodine remnant ablation and recombinant human thyroid-stimulating hormone preparation
F Vianello, R Mazzarotto, C Mian, O Lora, G Saladini… - Clinical Oncology, 2012 - Elsevier
AIM: Recombinant human thyroid-stimulating hormone (rhTSH) has been approved in
Europe as a preparation tool for radioiodine ablation of post-surgical thyroid remnants in …
Europe as a preparation tool for radioiodine ablation of post-surgical thyroid remnants in …